BIOPHARMACEUTICAL
ANALYTICAL DEVELOPMENT
PROVEN EXPERTISE
Your partner for regulatory-driven, phase-appropriate analytical programs tailored to
your product. We offer Total Quality Assurance expertise, helping you to navigate the
challenges of development, regulatory submission, and production.
BIOLOGICS | CELL & GENE THERAPIES | OLIGONUCLEOTIDES | PHARMACEUTICALS
• Experienced GLP/GCP and GMP laboratory services outsourcing partner
• Global drug delivery expertise
• Inhaled and nasal drug product development
• Structural characterisation and physicochemical properties (ICH Q6B)
• Clinical / preclinical bioanalysis (PK, ADA, Nab) and biomarker solutions
• Method development / validation and GMP analysis
• Comparability / biosimilar studies
• ATMP analytical and CMC support
• Cell based potency assays
• ICH stability programs
• Extractables / Leachables
biopharma@intertek.com +44 (0)116 296 1620
intertek.com/pharmaceutical/biopharmaceuticals
3rd ANNUAL
INHALED & NASAL
BIOLOGICS/DNA
FORUM 2024
26-27 SEPT | CAMBRIDGE, UK
Join us for a ground-breaking and
insightful forum on inhaled and nasal
biologics development.
Don't miss the opportunity to hear from
world-renowned industry leaders sharing the
latest learnings on inhaled & nasal biologics
and DNA medicine development, including
our keynote speaker, Dr Jenny Lam,
Associate Professor in Pharmaceutics
at the UCL School of Pharmacy, UK.
Find out more
online
